Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
基本信息
- 批准号:10468849
- 负责人:
- 金额:$ 8.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-13 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:Admission activityAnalgesicsAreaBedsBiometryCardiologyChildChildhoodClinicalClinical PharmacologyClinical ResearchClinical TrialsClinical Trials NetworkCollaborationsComprehensive Health CareContractsCritical CareCritical IllnessCritically ill childrenDataData Coordinating CenterDevelopmentDevelopment PlansDoctor of PhilosophyDrug LabelingElectronic Health RecordEnrollmentEnsureExtramural ActivitiesFacultyFundingGenerationsGoalsGood Clinical PracticeGovernmentIndividualInfantIntensive CareInterventionJointsLeadershipLifeMedicalMedicineMentorsMentorshipMorbidity - disease rateMulti-Institutional Clinical TrialNational Center for Advancing Translational SciencesNational Institute of Child Health and Human DevelopmentNetwork InfrastructureNorth CarolinaNutritional StudyParticipantPediatric Acute Lung InjuryPediatric HospitalsPerformancePharmaceutical PreparationsPharmacoepidemiologyPharmacologic SubstancePrincipal InvestigatorProceduresProtocols documentationPublic HealthPublicationsRecording of previous eventsResearchResearch InfrastructureResearch InstituteResearch PersonnelResearch TrainingResourcesScienceScientistSepsisServicesSiteSouth CarolinaTalentsTrainingUnited States Food and Drug AdministrationUnited States National Institutes of HealthUniversitiesWorkbasecareercareer developmentclinical research siteearly-career facultyexpectationexperienceimmunoregulationimproved outcomeinnovationmedical schoolsmeetingsmembermortalityparticipant enrollmentpediatric departmentpharmacometricsprogramsresearch studysedativesuccess
项目摘要
PROJECT SUMMARY/ABSTRACT - Duke University
Our overarching objective in joining the newly organized and expanded Collaborative Pediatric Critical Care
Research Network (CPCCRN) as a new site is to enhance the scientific breadth and reach of the network to
maximize its public health impact and improve outcomes for critically ill children. Our site, consisting of Duke
University (primary site) in Durham, North Carolina, and the Medical University of South Carolina (MUSC;
ancillary site) in Charleston, South Carolina, provides comprehensive care to > 4000 critically ill children per
year in both states. Our sites provide access to 89 combined pediatric intensive care bed, and together, we will
ensure that all critically ill children in the Carolinas have access to cutting edge clinical trials and research
studies performed by the CPCCRN. We are committed to improving outcomes of critically ill children through
collaborative multicenter clinical research. Over the past 3 years, we have enrolled >400 critically ill children in
15 clinical studies conducted at Duke and coordinated by leading multicenter clinical research networks. Our
site based research team is supported by a comprehensive departmental and school of medicine wide clinical
research infrastructure that provides full service administrative, financial, regulatory, and scientific support. Our
proposed research coordinator, Mrs Harward, has >5 years of experience conducting multicenter clinical trials
in critically ill children. Our proposed principal investigator, Dr. Hornik, has dedicated his professional life to
improving outcomes of critically ill children through the development of safe and effective drugs and
interventions. Dr. Hornik is board certified in pediatric critical care medicine and cardiology, has advanced
training in biostatistics and pharmaceutical sciences, and a track record of enrolling critically ill children in
clinical trials and mentoring early-career investigators. As a faculty member in both the Department of
Pediatrics and the Duke Clinical Research Institute (DCRI), the world’s largest academic research
organization, Dr. Hornik built a research and leadership portfolio ideally suited to enhance the scientific breadth
of the CPCCRN. Leveraging our experience coordinating large multicenter pediatric clinical research networks,
including the NICHD funded Pediatric Trials Network, the FDA supported Global Pediatric Clinical Trials
Network, and the NCATS Trial Innovations Network, and the resources accessible through the Division of
Quantitative Sciences and the DCRI Pharmacometrics Center, we will provide deep scientific expertise and
training and mentoring opportunities for CPCCRN investigators in the areas of clinical pharmacology, real-
world evidence generation, and regulatory science. Through our clinical reach and scientific expertise, we will
contribute significantly to the success of the CPCCRN, development of talented clinician scientists, and
completion of our highly innovative clinical trial aimed at reducing the morbidity and mortality of MODS in
critically ill infants and children.
项目摘要/摘要 - 杜克大学
我们的总体目标是加入新组织和扩大的协作儿科重症监护
研究网络(CPCCRN)作为一个新网站,旨在增强网络的科学广度和覆盖范围,
最大限度地发挥其公共卫生影响并改善危重儿童的治疗结果 我们的网站由杜克大学组成。
北卡罗来纳州达勒姆大学(主校区)和南卡罗来纳医科大学(MUSC;
位于南卡罗来纳州查尔斯顿的附属站点)为每 4000 名危重儿童提供全面护理
今年,我们的网站将在这两个州提供 89 张联合儿科重症监护床位。
确保卡罗莱纳州所有危重儿童都能获得最先进的临床试验和研究
我们致力于通过 CPCCRN 进行的研究来改善危重儿童的治疗结果。
在过去的 3 年里,我们已经招募了超过 400 名危重儿童。
15 项临床研究在杜克大学进行,并由我们领先的多中心临床研究网络协调。
现场研究团队得到了综合部门和医学院广泛临床的支持
提供全方位服务的行政、财务、监管和科学支持的研究基础设施。
拟议的研究协调员 Harward 女士拥有超过 5 年的多中心临床试验经验
我们提议的首席研究员霍尼克博士将他的职业生涯奉献给了重症儿童。
通过开发安全有效的药物来改善危重儿童的治疗结果
霍尼克博士获得了儿科重症监护医学和心脏病学委员会的认证,在干预方面取得了进展。
生物统计学和制药科学方面的培训,以及招收危重儿童的记录
作为两个系的教员,进行临床试验和指导早期职业研究人员。
儿科和世界上最大的学术研究杜克临床研究所 (DCRI)
霍尼克博士建立了一个非常适合增强科学广度的研究和领导组合
利用我们协调大型多中心儿科临床研究网络的经验,
包括 NICHD 资助的儿科试验网络、FDA 支持的全球儿科临床试验
网络、NCATS 试验创新网络,以及通过该部门获取的资源
定量科学和 DCRI 药物计量中心,我们将提供深厚的科学专业知识和
为 CPCCRN 研究人员提供临床药理学、实际应用领域的培训和指导机会
通过我们的临床影响力和科学专业知识,我们将生成世界证据和监管科学。
为 CPCCRN 的成功、才华横溢的临床科学家的发展做出了重大贡献,
完成我们高度创新的临床试验,旨在降低 MODS 的发病率和死亡率
危重婴儿和儿童。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christoph Hornik其他文献
Christoph Hornik的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christoph Hornik', 18)}}的其他基金
Digoxin Pharmacodynamics in Infants with Heart Failure due to Single Ventricle Congenital Heart Disease
地高辛在单心室先天性心脏病心力衰竭婴儿中的药效学
- 批准号:
10464211 - 财政年份:2022
- 资助金额:
$ 8.31万 - 项目类别:
Digoxin Pharmacodynamics in Infants with Heart Failure due to Single Ventricle Congenital Heart Disease
地高辛在单心室先天性心脏病心力衰竭婴儿中的药效学
- 批准号:
10600853 - 财政年份:2022
- 资助金额:
$ 8.31万 - 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
- 批准号:
10393859 - 财政年份:2021
- 资助金额:
$ 8.31万 - 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
- 批准号:
10470945 - 财政年份:2021
- 资助金额:
$ 8.31万 - 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
- 批准号:
10248818 - 财政年份:2021
- 资助金额:
$ 8.31万 - 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
- 批准号:
10670216 - 财政年份:2021
- 资助金额:
$ 8.31万 - 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
- 批准号:
10670245 - 财政年份:2021
- 资助金额:
$ 8.31万 - 项目类别:
Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia
西地那非在患有严重支气管肺发育不良的早产儿中的安全性
- 批准号:
9795582 - 财政年份:2019
- 资助金额:
$ 8.31万 - 项目类别:
Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia
西地那非在患有严重支气管肺发育不良的早产儿中的安全性
- 批准号:
10017313 - 财政年份:2019
- 资助金额:
$ 8.31万 - 项目类别:
Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia
西地那非在患有严重支气管肺发育不良的早产儿中的安全性
- 批准号:
10274808 - 财政年份:2019
- 资助金额:
$ 8.31万 - 项目类别:
相似国自然基金
芳基氨甲基-哌啶/四氢萘类μ/δ阿片受体双重功效镇痛分子成药性研究
- 批准号:81773635
- 批准年份:2017
- 资助金额:48.0 万元
- 项目类别:面上项目
长效阿片类镇痛药物镇痛与依赖分离的机制研究
- 批准号:81402911
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
运用代谢组学技术系统研究乌头碱类镇痛药的体内活性/毒性代谢产物
- 批准号:81302844
- 批准年份:2013
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
δ、μ、κ 阿片受体三重激动剂的作用机制研究
- 批准号:81173029
- 批准年份:2011
- 资助金额:14.0 万元
- 项目类别:面上项目
去甲肾上腺素α2A受体的镇痛调节新靶点- - -CSK
- 批准号:81072626
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
- 批准号:
10248818 - 财政年份:2021
- 资助金额:
$ 8.31万 - 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
- 批准号:
10670245 - 财政年份:2021
- 资助金额:
$ 8.31万 - 项目类别:
Developing a public health measure of built environment to assess risk of nonmedical opioid use and related mortality in urban and non-urban areas in New Jersey
制定建筑环境公共卫生措施,以评估新泽西州城市和非城市地区非医疗阿片类药物使用和相关死亡率的风险
- 批准号:
9746108 - 财政年份:2020
- 资助金额:
$ 8.31万 - 项目类别:
Longitudinal Patterns of Symptoms, Medication and Hospice Use in Nursing Home Residents Approaching End of Life
临终疗养院居民的症状、药物治疗和临终关怀服务的纵向模式
- 批准号:
10264797 - 财政年份:2020
- 资助金额:
$ 8.31万 - 项目类别:
Longitudinal Patterns of Symptoms, Medication and Hospice Use in Nursing Home Residents Approaching End of Life
临终疗养院居民的症状、药物治疗和临终关怀使用的纵向模式
- 批准号:
10662447 - 财政年份:2020
- 资助金额:
$ 8.31万 - 项目类别: